Another notable buy includes CRISPR Therapeutics AG (NASDAQ: CRSP ), with ARKK ETF purchasing 31,983 shares, reflecting a continued investment in the gene-editing company with a total dollar value of ...

On Tuesday, Cathie Wood ‘s Ark Invest made significant moves by selling shares of Palantir Technologies Inc . PLTR and Archer ...

Tech investor and CEO of ARK Invest, Cathie Wood, on Friday re-emphasized her bullish calls on Bitcoin (CRYPTO: BTC) and ...

In smaller transactions, ARK sold shares of Adaptive Biotechnologies Corp (NASDAQ: ADPT) and CareDx Inc (NASDAQ: CDNA ), and bought shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Veracyte Inc ...

Throughout her tenure as CEO and chief investment officer of Ark Invest, Cathie Wood earned her reputation as an investor by ...

Cathie Wood’s ARK ETFs have published their daily trades for Wednesday, May 7th, 2025, revealing a series of significant transactions in the tech and biotech sectors. The largest dollar-value trade of ...

While the companies above are each disruptive in their own right and stand to benefit from the prospects of artificial intelligence (AI), none trade for ... at Ark suggests Wood has her eyes ...

Throughout her tenure as CEO and chief investment officer of Ark Invest, Cathie ... none trade for a particularly bargain valuation. Instead, recent buying activity at Ark suggests Wood has ...

Leaders are thriving amid a rangebound market. Tesla topped an entry. Palantir is setting up. U.S.-China trade talks loom.